G. B. Vogelsang
- Hematology top 1%
- Immunology top 10%
- Oncology top 10%
- Genetics top 5%
- Public Health, Environmental and Occupational Health top 10%
- Co-authors
- V AltomonteMary S. LeffellRichard J. JonesPaul V. O’DonnellEphraim J. FuchsLeo LuznikS PiantadosiKenneth H. Cowan
- Topics
- Hematopoietic Stem Cell Transplantation (20 papers)Acute Myeloid Leukemia Research (6 papers)Multiple Myeloma Research and Treatments (4 papers)
- Cited by
- HematologyTransplantationImmunology
- Journals
- Journal of Clinical OncologyBloodInternational Journal of Radiation Oncology*Biology*Physics
- Partner nations
- United StatesGermanyCanada
In The Last Decade
G. B. Vogelsang
28 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 73
- Hematology 963
- Immunology 405
- Oncology 267
- Genetics 186
- Public Health, Environmental and Occupational Health 160
Countries citing papers authored by G. B. Vogelsang
This map shows the geographic impact of G. B. Vogelsang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. B. Vogelsang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. B. Vogelsang more than expected).
Fields of papers citing papers by G. B. Vogelsang
This network shows the impact of papers produced by G. B. Vogelsang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. B. Vogelsang. The network helps show where G. B. Vogelsang may publish in the future.
Co-authorship network of co-authors of G. B. Vogelsang
This figure shows the co-authorship network connecting the top 25 collaborators of G. B. Vogelsang. A scholar is included among the top collaborators of G. B. Vogelsang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. B. Vogelsang. G. B. Vogelsang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 73 | |
| 3 | 6 | |
| 4 | 35 | |
| 5 | 324 | |
| 6 | 11 | |
| 7 | 21 | |
| 8 | An old drug for a new disease: pentostatin (Nipent) in acute graft-versus-host disease. | 17 |
| 9 | 85 | |
| 10 | 58 | |
| 11 | 16 | |
| 12 | 1 | |
| 13 | 8 | |
| 14 | 64 | |
| 15 | 50 | |
| 16 | Using elutriation to engineer bone marrow allografts. | 4 |
| 17 | 101 | |
| 18 | 10 | |
| 19 | 12 | |
| 20 | Thalidomide, a potent agent for the treatment of graft-versus-host disease | 17 |
About G. B. Vogelsang
G. B. Vogelsang is a scholar working on Hematology, Transplantation and Emergency Medicine, having authored 28 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (20 papers), Acute Myeloid Leukemia Research (6 papers) and Multiple Myeloma Research and Treatments (4 papers). The work is most often cited by research in Hematology (963 citations), Transplantation (116 citations) and Immunology (405 citations). G. B. Vogelsang has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include V Altomonte, Mary S. Leffell, Richard J. Jones, Paul V. O’Donnell, Ephraim J. Fuchs, Leo Luznik, S Piantadosi, Kenneth H. Cowan, Mitch A. Phelps and Bijoyesh Mookerjee. Their work appears in journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.